ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2309

Clinical Study of Peripheral Blood Lymphocyte Subsets in Patients with Rheumatoid Arthritis Complicated with Osteoporosis

Ting Cheng1, Sheng-xiao Zhang 2, Xiao-qing Liu 1, Jia Wang 1, Chong Gao 3 and Xiao-feng Li 1, 1The Second Hospital of Shanxi Medical University, Taiyuan, China (People's Republic), 2The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China (People's Republic), 3Brigham and Women’s Hospital, Harvard Medical School, Boston

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: B cells and T-Regulatory Cells, osteoporosis, Rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: RA – Diagnosis, Manifestations, & Outcomes Poster III: Comorbidities

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis(RA) is an autoimmune disease mainly manifested by aggressive polyarthritis.The incidence of osteoporosis(OP) has risen and the risk of fracture has further increased in parallel with the prolongation of the disease course,which seriously affects the prognosis and the quality of patients’lives.The purpose of this study is to investigate the incidence of OP in patients with RA and the status of peripheral lymphocyte subsets.

Methods: A total of 734 patients with RA and 81 healthy controls (HC) were enrolled in this study. All peripheral lymphocyte subsets of these participants were assessed by flow cytometry. Patients were divided to pure RA group and RA-OP group according to their bone mineral density (BMD) of lumbar or bilateral hip and the history of fragility fracture for further comparation of the general clinical data as well as the status of peripheral lymphocyte subsets among these participants.

Results: Among 181 (24.93%) RA-OP patients, there were more female (P=0.021), suggesting female is more susceptible to develop OP. Compared with pure RA patients, not only an older age (P< 0.001) and a longer disease duration(P< 0.001) but also a higher disease activity was observed in RA-OP patients. Moreover, RA-OP patients suffered more joints swelling and pain (P< 0.05) as well as ESR(P< 0.001) and CRP(P=0.014) (Table 1). Compared with those of HC and RA group, the number of Th17 in RA-OP patients was significantly increased (P< 0.05), while Treg cells decreased (p< 0.05), leading to a higher ratio of Th17/Tregs (P< 0.05) (Table 2). In addition, the level of B cells in the pure RA or RA-OP group was significantly reduced, and this alteration was more obvious in patients with OP.

Conclusion: RA patients have a high incidence of OP, which was related to gender, age,disease duration and disease activity. Notably, immune disorder caused by Th17/Treg imbalance may also contribute to OP in RA patients. In addition, total B cells trended to decrease. Anti-osteoporosis treatment and immune regulation might be considered at the early stage of disease.

Figure1:The levels of B、Th17、Treg cells and the ratio of Th17/Treg among HC, pure RA and RA-OP group.-*P<0.05;**P<0.01;***P<0.001-.


Disclosure: T. Cheng, None; S. Zhang, None; X. Liu, None; J. Wang, None; C. Gao, None; X. Li, None.

To cite this abstract in AMA style:

Cheng T, Zhang S, Liu X, Wang J, Gao C, Li X. Clinical Study of Peripheral Blood Lymphocyte Subsets in Patients with Rheumatoid Arthritis Complicated with Osteoporosis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/clinical-study-of-peripheral-blood-lymphocyte-subsets-in-patients-with-rheumatoid-arthritis-complicated-with-osteoporosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-study-of-peripheral-blood-lymphocyte-subsets-in-patients-with-rheumatoid-arthritis-complicated-with-osteoporosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology